TABLE 11.
TREATED EYES (n=203) 148 EYES TESTED | CONTROL EYES (n=203) 146 EYES TESTED | COMBINED EYES (n=406) 294 EYES TESTED | ELBW COHORT (n=64) | |
---|---|---|---|---|
Favorable | 79 (53.4%) | 62 (42.5%) | 141 (48.0%) | 52 (81.3%) |
Normal | 43 (29.1%) | 42 (28.8%) | 85 (28.9%) | 38 (59.4%) |
Below normal | 36 (24.3%) | 20 (13.7%) | 56 (19.1%) | 14 (21.9%) |
Unfavorable | 69 (46.6%) | 84 (57.5%) | 153 (52.0%) | 12 (18.8%) |
Poor vision | 14 (9.5%) | 6 (4.1%) | 20 (6.8%) | 1 (1.5%) |
Blind/low vision | 55 (37.2%) | 78 (53.4%) | 133 (45.2%) | 11 (17.2%) |
CRYO-ROP = Cryotherapy for Retinopathy of Prematurity.